Catalyst Wire Dossier Catalyst Wire Dossier

HMG-CoA reductase inhibitor add-on therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMG-CoA reductase inhibitor add-on therapy, covering 2020-12-14 to 2020-12-14. Get the full timeline:

Most recent: Clinical Trial Update: HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria [Phase 4]

See pricing